Immune to Cancer: The CRI Blog
-
Marika H’s Immunotherapy Story
Kidney Cancer | Diagnosed Age 50 I came to the realization that you only have two choices: you… -
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer
The trial ended early because data showed that patients lived longer on nivolumab compared to the standard-of-care…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 1
A day for travel and educational sessions at the American Society of Clinical Oncology (ASCO).